The fresh issue size of Rs 602 crore is down from the originally envisaged issue of Rs 750 crore, and includes a pre-IPO placement of about Rs 62 crore consisting of 26,27,697 equity shares issued at a price of Rs 236 per equity share to one of its promoters THCL, by way of a rights issue.
Vijay Kedia buys 9 lakh shares of SME stock Mahamaya Lifesciences in Rs 12.5 crore block deal
Ace investor Vijay Kedia acquired a significant stake in Mahamaya Lifesciences through a block deal. He purchased nearly 9 lakh shares at Rs 140 each.